10x Genomics, Inc. Form 8-K Summary
Business Context and Reporting Period
10x Genomics, Inc. filed a Current Report on Form 8-K dated August 4, 2021, reporting the issuance of a press release containing financial results for the quarter ended June 30, 2021.
Financial Results and Key Metrics
The filing text does not include the financial results from the referenced press release. Revenue, profit or loss, cash flow, margins, debt, liquidity, and other key financial metrics are therefore not clearly provided.
Material Changes Versus the Prior Comparable Period
The filing text does not provide a comparison with the prior-year or prior-quarter period and does not identify specific material changes.
Guidance, Outlook, Risks, and Unusual Items
The filing text does not provide guidance, outlook commentary, risk disclosures, contingencies, or unusual items. Exhibit 99.1 is a press release dated August 4, 2021, but its contents are not included in the provided filing text.
The information under Item 2.02 and the attached press release were furnished rather than filed for purposes of Section 18 of the Exchange Act and are not incorporated by reference into other filings except where expressly stated.
Key Facts for Investor Verification
- Obtain and review Exhibit 99.1 for the actual quarterly financial results and management commentary.
- Verify revenue, net income or loss, cash flow, cash and investments, debt, liquidity, and operating margins for the quarter ended June 30, 2021.
- Check the press release for year-over-year and sequential comparisons, updated guidance, and identified business risks or contingencies.
- Confirm whether any non-GAAP measures are presented and reconcile them to the applicable GAAP measures.